Preventza Ourania, Garcia Andrea, Kashyap Sarang A, Akvan Shahab, Cooley Denton A, Simpson Kiki, Rammou Athina, Price Matt D, Omer Shuab, Bakaeen Faisal G, Cornwell Lorraine D, Coselli Joseph S
Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA
Department of Cardiovascular Surgery, Texas Heart Institute, Houston, TX, USA.
Eur J Cardiothorac Surg. 2016 Nov;50(5):949-954. doi: 10.1093/ejcts/ezw163. Epub 2016 May 17.
To determine whether, in patients with previous cardiac operations, moderate hypothermia (between 24 and 28°C) for hypothermic circulatory arrest (HCA) during antegrade cerebral perfusion (ACP) is safe for use during surgery on the proximal aorta and transverse aortic arch.
Over a 7-year period, 118 patients underwent ascending aortic and hemiarch repair (n = 70; 59.3%), total arch replacement (n = 47; 39.8%) or ascending aortic replacement to treat porcelain aorta (n = 1; 0.9%). Simultaneous procedures included aortic root repair or replacement (n = 33; 28.0%) and coronary artery bypass grafting (n = 21; 17.8%). All patients had previously undergone cardiac operations via a median sternotomy. Eighteen patients (15.3%) had more than 1 previous sternotomy, and 24 patients (20.3%) required emergent/urgent operation. Median cardiopulmonary bypass, cardiac ischaemic, circulatory arrest and ACP times (min) were 136.0 [118-180 interquartile range (IQR)], 91.0 (68-119 IQR), 34.0 (21-59 IQR) and 33.5 (20-59 IQR), respectively. The median temperature when HCA was initiated was 24.2°C (24.1-24.8°C IQR).
The operative mortality rate was 10.2% (n = 12). Six patients (5.1%) had a permanent stroke, and 16 patients (13.6%) had a composite adverse outcome (operative mortality and/or a permanent neurological event and/or permanent haemodialysis at discharge). Preoperative renal disease was significantly more prevalent (P= 0.020) and the median circulatory arrest time significantly longer (48.5 vs 33 min; P= 0.058) in patients with composite adverse outcomes. Multivariable analysis of the redo patients showed that age (P =0.025), preoperative renal disease (P =0.024) and ACP time (P =0.012) were independent risk factors for a new postoperative renal injury.
Moderate hypothermia for HCA during ACP is being used with increasing frequency, but has not been thoroughly evaluated in patients undergoing cardiovascular reoperations. Our experience suggests that in patients with previous cardiac surgery who are undergoing hemiarch and total aortic arch operations, moderate hypothermia is safe and produces respectable results.
确定在既往接受过心脏手术的患者中,在顺行性脑灌注(ACP)期间进行低温循环停搏(HCA)时,中度低温(24至28°C)用于升主动脉和主动脉弓横部手术是否安全。
在7年期间,118例患者接受了升主动脉和半弓修复术(n = 70;59.3%)、全弓置换术(n = 47;39.8%)或升主动脉置换术以治疗瓷化主动脉(n = 1;0.9%)。同期手术包括主动脉根部修复或置换(n = 33;28.0%)和冠状动脉旁路移植术(n = 21;17.8%)。所有患者既往均通过正中胸骨切开术接受过心脏手术。18例患者(15.3%)既往有超过1次胸骨切开术,24例患者(20.3%)需要急诊/紧急手术。体外循环、心脏缺血、循环停搏和ACP时间的中位数(分钟)分别为136.0[四分位间距(IQR)为118 - 180]、91.0(68 - 119 IQR)、34.0(21 - 59 IQR)和33.5(20 - 59 IQR)。开始HCA时的中位温度为24.2°C(IQR为24.1 - 24.8°C)。
手术死亡率为10.2%(n = 12)。6例患者(5.1%)发生永久性卒中,16例患者(13.6%)出现复合不良结局(手术死亡和/或永久性神经事件和/或出院时永久性血液透析)。复合不良结局患者术前肾病的患病率显著更高(P = 0.020),中位循环停搏时间显著更长(48.5对33分钟;P = 0.058)。对再次手术患者的多变量分析显示,年龄(P = 0.025)、术前肾病(P = 0.024)和ACP时间(P = 0.012)是术后新发肾损伤的独立危险因素。
在ACP期间进行HCA时使用中度低温的频率越来越高,但在接受心血管再次手术的患者中尚未得到充分评估。我们的经验表明,对于既往接受过心脏手术且正在接受半弓和全主动脉弓手术的患者,中度低温是安全的,并且能产生不错的结果。